Skip to main content

Type B natriuretic peptide stability in frozen plasma.

Daves M, Cemin R

Publication: Clin Chem Lab Med (2007) • Vol 45 • Page 1257-8PMID: 17848123View on PubMed

Purpose

The purpose of this paper was to investigate the effects of freezing, freeze thaw cycling and cardiovascular disease on the stability of B type-natriuretic peptide (BNP) in plasma specimens without the addition of protease inhibitors.

Conclusion

In normal specimens, no effect of freezing and storage of specimen for 30 days, or up to 10 freeze thaw cycles was found on the BNP levels. In contrast, BNP present at pathologically high levels (cardiovascular disease) was found to diminish with freezing and storage for 30 d and with freeze thaw cycling. In conclusion, frozen plasma may be reliably used to measure BNP in normal specimens, but not in specimens expected to have pathologically high levels.

Studies (1)

Purpose

The purpose of this study was to investigate the effects of freezing and storage for 30 d, freeze thaw cycling (0, 2, 5, or 10 cycles) and cardiovascular disease on the stability of BNP in plasma specimens without the addition of protease inhibitors.

Summary of Findings

BNP in fresh specimens from 29 healthy individuals ranged from 18-133 ng/L with an average of 57 ng/L. After freezing the specimen and storing it for 30 days at -20 degrees C, no significant change in the mean BNP level for normal specimens was observed. In contrast, the measured BNP in 38 specimens from individuals with cardiovascular disease decreased from an average of 1183 ng/L in fresh specimens to 1108 ng/L (p<0.0001) in specimens frozen for 30 days. Freeze-thaw cycling had no significant effect on BNP levels in three normal specimens, but did result in a progressive decline in 11 specimens from individuals with cardiovascular disease (p=0.04). The authors conclude that at normal physiological levels, BNP is stable through freezing and storage of at least 30 days, and through at least 10 freeze thaw cycles, but at pathological levels, BNP levels decrease over time and with freezing.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    FrozenNone (Fresh)
  • Diagnoses

    Cardiovascular Disease
    Normal
  • Platforms

    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Cardiovascular disease
    Normal
    Biospecimen PreservationType of fixation/preservation
    Frozen
    None (fresh)
    StorageFreeze/thaw cycling
    0 cycles
    10 cycles
    2 cycles
    5 cycles
    StorageStorage duration
    0 d
    30 d